Young Su Yoon

Title: Young Su Yoon: Innovator in Pharmaceutical Composition

Introduction

Young Su Yoon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid formulations for cardiovascular disorders. With a total of 2 patents, his work focuses on enhancing drug delivery efficiency and stability.

Latest Patents

One of his latest patents is titled "Solid pharmaceutical composition comprising amlodipine and losartan." This invention provides a pharmaceutical composition aimed at preventing or treating cardiovascular disorders. It includes losartan or a pharmaceutically acceptable salt thereof, amlodipine or a pharmaceutically acceptable salt thereof, a disintegrant, and a coating agent. The composition boasts an optimal ratio of disintegrant to coating agent, ensuring sufficient strength and high dissolution rates across various pH environments. This innovation is particularly useful for creating solid formulations that exhibit improved drug delivery efficiency and storage stability.

Another notable patent is "Amorphous solid dispersion comprising taxane, tablet comprising the same, and method for preparing the same." This invention includes an amorphous solid dispersion that contains a taxane or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable polymer, and a surfactant, which enhances solubility. The patent also outlines a method for preparing the solid dispersion and provides a tablet that demonstrates good solubility, bioavailability, and stability.

Career Highlights

Young Su Yoon is currently associated with Hanmi Pharm. Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing formulations that improve patient outcomes.

Collaborations

He collaborates with notable colleagues, including Ho Taek Im and Yong Il Kim, who contribute to his research and development efforts.

Conclusion

Young Su Yoon is a key figure in the pharmaceutical industry, with a focus on developing innovative compositions that enhance drug delivery and stability. His contributions are paving the way for advancements in the treatment of cardiovascular disorders.